Specialty Endocrinology
-
Featured
Preventing Heart Disease After HIV Infection
Research at Massachusetts General Hospital has led to several landmark studies, including the REPRIEVE trial, aimed at understanding and preventing HIV-related heart disease.
-
Featured
Diet High in Plant Foods Linked to Lower Risk, Severity of COVID-19
Jordi Merino, PhD, Andrew T. Chan, MD, MPH, and colleagues found that among 592,571 adults in the U.S. and U.K., a diet high in healthy plant foods was associated with lower risk and severity of COVID-19, even after accounting for health status, health behaviors, socioeconomic status and virus transmission measures.
-
Early Increase in Physical Activity Predicts Longer-term Improvement by Patients With Type 2 Diabetes
Emily H. Feig, PhD, and Jeff C. Huffman, MD, of the Department of Psychiatry, and colleagues suggest that when patients with type 2 diabetes and low self-reported physical activity take part in a behavioral intervention, their early progress is a good predictor of their longer-term improvement in activity.
-
Newly Identified Genetic Variant Has Substantial Effect on Risk of Type 2 Diabetes
Most genome-wide association studies (GWAS) are likely to miss variants with recessive effects. In a large recessive-model GWAS, Massachusetts General Hospital researchers identified a novel locus associated with 2.56 greater risk of type 2 diabetes in homozygous carriers that also had substantial effects on lipids.
-
Review: Use of Diabetes Technology by Patients With Cystic Fibrosis
Melissa S. Putman, MD, Jordan S. Sherwood, MD, and colleagues give practical tips for how patients with cystic fibrosis–related diabetes can make the best use of continuous glucose monitors, insulin pumps and automated insulin delivery systems.
-
SGK1 May Be Novel Target for Treating Type 2 Diabetes
Alexander A. Soukas, PhD, MD, Ben Zhou, PhD, and colleagues propose hepatic serum- and glucocorticoid-induced kinase could improve the ability of insulin to lower blood glucose without promoting hepatic steatosis in patients with type 2 diabetes.
Endocrinology Contributors
-
Camille E. Powe, MD
Endocrinologist, Massachusetts General Hospital, Co-Director, Diabetes in Pregnancy Program
Recent Article
Carbohydrate Intake Before Oral Glucose Tolerance Test May Prevent Accurate Diagnosis of Gestational Diabetes
-
Elizabeth A. Lawson, MD
Clinician, Neuroendocrine Clinical Center, Massachusetts General Hospital, Faculty, Neuroendocrine Unit, Massachusetts General Hospital, Assistant Professor of Medicine, Harvard Medical School
Recent Article
Restrictive Eating Disorders May Disrupt White Matter Development -
Joel S. Finkelstein, MD
Endocrinologist, Massachusetts General Hospital, Associate Director, Bone Density Center, Endocrine Unit, Massachusetts General Hospital
Recent Article
Ivacaftor Improves Skeletal Outcomes in Patients with Cystic Fibrosis -
Jose C. Florez, MD, PhD
Chief, Diabetes Unit, Endocrine Division, John T. Potts Jr., MD Endowed Chair in Medicine, Massachusetts General Hospital, Professor of Medicine, Harvard Medical School
Recent Article
Newly Identified Genetic Variant Has Substantial Effect on Risk of Type 2 Diabetes
-
Melissa S. Putman, MD
Endocrinologist, Massachusetts General Hospital, Assistant Professor of Pediatrics, Harvard Medical School
Recent Article
Review: Use of Diabetes Technology by Patients With Cystic Fibrosis -
Steven Kyle Grinspoon, MD
Chief, Metabolism Unit, Massachusetts General Hospital, Director, Nutrition Obesity Research Center, Harvard
Recent Article
Preventing Heart Disease After HIV Infection
Endocrinology Division
The Endocrinology Division at Massachusetts General Hospital offers a comprehensive integrated program of clinical services for both primary and tertiary care of adults with endocrine disorders.